Coya Therapeutics (COYA) Assets Average (2023 - 2025)
Coya Therapeutics (COYA) has disclosed Assets Average for 3 consecutive years, with $41.0 million as the latest value for Q4 2025.
- Quarterly Assets Average rose 2.62% to $41.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $41.0 million through Dec 2025, up 2.62% year-over-year, with the annual reading at $47.1 million for FY2025, 10.15% up from the prior year.
- Assets Average hit $41.0 million in Q4 2025 for Coya Therapeutics, up from $32.7 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $41.4 million in Q1 2025 to a low of $12.9 million in Q1 2023.
- Historically, Assets Average has averaged $31.3 million across 3 years, with a median of $36.8 million in 2024.
- Biggest five-year swings in Assets Average: surged 204.7% in 2024 and later fell 13.24% in 2025.
- Year by year, Assets Average stood at $26.6 million in 2023, then soared by 50.31% to $39.9 million in 2024, then rose by 2.62% to $41.0 million in 2025.
- Business Quant data shows Assets Average for COYA at $41.0 million in Q4 2025, $32.7 million in Q3 2025, and $35.9 million in Q2 2025.